DTaP-HepB-IPV-Hib vaccine

BIOLOGICAL3 trials

Sponsors

LG Chem, Sanofi Pasteur, a Sanofi Company

Conditions

DiphtheriaHaemophilus Influenzae Type B InfectionHaemophilus Influenzae Type b InfectionHealthy VolunteersHepatitis BMeningococcal ImmunizationPertussisPoliomyelitis

Phase 1

A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults

LG ChemDiphtheria, Haemophilus Influenzae Type b Infection, Hepatitis B +3

Start: 2023-07-17End: 2024-03-31Target: 42Updated: 2023-07-19

Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

Active, not recruitingNCT06647407

Sanofi Pasteur, a Sanofi CompanyHealthy Volunteers, Meningococcal Immunization

Start: 2024-11-05End: 2027-05-17Target: 750Updated: 2026-01-20

Phase 2

Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age

Not yet recruitingNCT06618196

LG ChemDiphtheria, Haemophilus Influenzae Type B Infection, Hepatitis B +3

Start: 2024-10-02End: 2026-04-30Target: 336Updated: 2024-10-01